200 related articles for article (PubMed ID: 35653587)
21. [Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia].
Yin J; Sun AN; Tian XP; Tian H; Wang RX; Yang Z; Wang XL; Wu DP; Qiu HY; Pan JL; Cen JN; Liang JY; Chen SN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):39-44. PubMed ID: 23484688
[TBL] [Abstract][Full Text] [Related]
22. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
Chen X; Fan S; Zhao Y; Zhou J
Clin Transl Oncol; 2021 Oct; 23(10):2171-2180. PubMed ID: 33942222
[TBL] [Abstract][Full Text] [Related]
23. Validation of a Molecular Risk Score for Prognosis of Patients With Acute Promyelocytic Leukemia Treated With All-trans Retinoic Acid and Chemotherapy-containing Regimens.
Hecht A; Doll S; Altmann H; Nowak D; Lengfelder E; Röllig C; Ehninger G; Spiekermann K; Hiddemann W; Weiß C; Hofmann WK; Nolte F; Platzbecker U
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):889-896.e5. PubMed ID: 28923666
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia.
Ding Y; Liu Z; Wang H; Xiong S; Zhai Z
Scand J Clin Lab Invest; 2023 Sep; 83(5):340-347. PubMed ID: 37355341
[TBL] [Abstract][Full Text] [Related]
25. Coordinated regulation of the immunoproteasome subunits by PML/RARα and PU.1 in acute promyelocytic leukemia.
Yang XW; Wang P; Liu JQ; Zhang H; Xi WD; Jia XH; Wang KK
Oncogene; 2014 May; 33(21):2700-8. PubMed ID: 23770850
[TBL] [Abstract][Full Text] [Related]
26. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
27. Analysis of WT1 mutations, expression levels and single nucleotide polymorphism rs16754 in de novo non-M3 acute myeloid leukemia.
Luo S; Yu K; Yan QX; Shen ZJ; Wu JB; Chen HM; Gao SM
Leuk Lymphoma; 2014 Feb; 55(2):349-57. PubMed ID: 23550990
[TBL] [Abstract][Full Text] [Related]
28. Incidence and Prognostic Impact of WT-1 Gene Exon7 and 9 Mutations in Acute Promyelocytic Leukemia.
Nejatifar F; Rostami S; Chahardouli B; Kasaeian A; Vaezi M; Kamranzadeh H; Mousavi SA; Farbod A; Alimoghaddam K; Ghavamzadeh A
Int J Hematol Oncol Stem Cell Res; 2022 Apr; 16(2):74-80. PubMed ID: 36304735
[No Abstract] [Full Text] [Related]
29. Dynamic long-range chromatin interactions control Myb proto-oncogene transcription during erythroid development.
Stadhouders R; Thongjuea S; Andrieu-Soler C; Palstra RJ; Bryne JC; van den Heuvel A; Stevens M; de Boer E; Kockx C; van der Sloot A; van den Hout M; van Ijcken W; Eick D; Lenhard B; Grosveld F; Soler E
EMBO J; 2012 Feb; 31(4):986-99. PubMed ID: 22157820
[TBL] [Abstract][Full Text] [Related]
30. Histone acetyltransferase p300 promotes the activation of human WT1 promoter and intronic enhancer.
Shao Y; Lu J; Zhang G; Liu C; Huang B
Arch Biochem Biophys; 2005 Apr; 436(1):62-8. PubMed ID: 15752709
[TBL] [Abstract][Full Text] [Related]
31. A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report.
Grassilli S; Nika E; Lambertini E; Brugnoli F; Piva R; Capitani S; Bertagnolo V
Cell Oncol (Dordr); 2016 Oct; 39(5):483-489. PubMed ID: 27480083
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional repression of CDKN2D by PML/RARα contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells.
Wang Y; Jin W; Jia X; Luo R; Tan Y; Zhu X; Yang X; Wang X; Wang K
Cell Death Dis; 2014 Oct; 5(10):e1431. PubMed ID: 25275592
[TBL] [Abstract][Full Text] [Related]
33. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
Rampal R; Alkalin A; Madzo J; Vasanthakumar A; Pronier E; Patel J; Li Y; Ahn J; Abdel-Wahab O; Shih A; Lu C; Ward PS; Tsai JJ; Hricik T; Tosello V; Tallman JE; Zhao X; Daniels D; Dai Q; Ciminio L; Aifantis I; He C; Fuks F; Tallman MS; Ferrando A; Nimer S; Paietta E; Thompson CB; Licht JD; Mason CE; Godley LA; Melnick A; Figueroa ME; Levine RL
Cell Rep; 2014 Dec; 9(5):1841-1855. PubMed ID: 25482556
[TBL] [Abstract][Full Text] [Related]
34. Incidences and Prognostic Impact of c-KIT, WT1, CEBPA, and CBL Mutations, and Mutations Associated With Epigenetic Modification in Core Binding Factor Acute Myeloid Leukemia: A Multicenter Study in a Korean Population.
Park SH; Lee HJ; Kim IS; Kang JE; Lee EY; Kim HJ; Kim YK; Won JH; Bang SM; Kim H; Song MK; Chung JS; Shin HJ
Ann Lab Med; 2015 May; 35(3):288-97. PubMed ID: 25932436
[TBL] [Abstract][Full Text] [Related]
35. PML/RARa blocks the differentiation and promotes the proliferation of acute promyelocytic leukemia through activating MYB expression by transcriptional and epigenetic regulation mechanisms.
Wang G; Tian Y; Hu Q; Xiao X; Chen S
J Cell Biochem; 2019 Feb; 120(2):1210-1220. PubMed ID: 30335887
[TBL] [Abstract][Full Text] [Related]
36. LncRNA KCNQ1OT1 activated by c-Myc promotes cell proliferation via interacting with FUS to stabilize MAP3K1 in acute promyelocytic leukemia.
Tang D; Luo Y; Jiang Y; Hu P; Peng H; Wu S; Zhang G; Wang Y
Cell Death Dis; 2021 Aug; 12(9):795. PubMed ID: 34404765
[TBL] [Abstract][Full Text] [Related]
37. Loss of imprinting at the 14q32 domain is associated with microRNA overexpression in acute promyelocytic leukemia.
Manodoro F; Marzec J; Chaplin T; Miraki-Moud F; Moravcsik E; Jovanovic JV; Wang J; Iqbal S; Taussig D; Grimwade D; Gribben JG; Young BD; Debernardi S
Blood; 2014 Mar; 123(13):2066-74. PubMed ID: 24493669
[TBL] [Abstract][Full Text] [Related]
38. The tumor suppressor gene DAPK2 is induced by the myeloid transcription factors PU.1 and C/EBPα during granulocytic differentiation but repressed by PML-RARα in APL.
Humbert M; Federzoni EA; Britschgi A; Schläfli AM; Valk PJ; Kaufmann T; Haferlach T; Behre G; Simon HU; Torbett BE; Fey MF; Tschan MP
J Leukoc Biol; 2014 Jan; 95(1):83-93. PubMed ID: 24038216
[TBL] [Abstract][Full Text] [Related]
39. WT1 mutations and single nucleotide polymorphism rs16754 analysis of patients with pediatric acute myeloid leukemia in a Chinese population.
Chen X; Yang Y; Huang Y; Tan J; Chen Y; Yang J; Dou H; Zou L; Yu J; Bao L
Leuk Lymphoma; 2012 Nov; 53(11):2195-204. PubMed ID: 22506617
[TBL] [Abstract][Full Text] [Related]
40. PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu ZM; Chin KV; Liu JH; Lozano G; Chang KS
Mol Cell Biol; 1994 Oct; 14(10):6858-67. PubMed ID: 7935403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]